Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has entered into a Letter of Intent ("LOI"), through its wholly owned subsidiary CosmoFarm S.A. ("CosmoFarm"), with respect to the acquisition of an extensive pharmacy distribution network from an established pharmaceutical company serving the Greek market for almost 40 years. The term of the LOI is ninety (90) days from March 6, 2026.
The network currently generates approximately €10 million (approximately $11.5 million based on the prevailing EUR/USD exchange rate) in annual gross revenue and serves a broad base of pharmacy customers, supplying both pharmaceutical and para-pharmaceutical products.
The acquisition is expected to expand CosmoFarm's commercial reach and strengthen its distribution footprint. Once integrated into CosmoFarm's automated logistics platform, which utilizes advanced robotic technologies for procurement, inventory management, and order execution, the network is expected to benefit from improved operating efficiencies and enhanced service levels for pharmacies.
This transaction, which remains subject to the execution of the acquisition agreement containing the customary closing conditions, forms part of the Company's broader strategy to reach the revenue target for 2027 outlined in its previously announced guidance of $155.8 million. Cosmos Health intends to achieve this objective through a combination of organic growth across its core operating segments and a disciplined acquisition strategy designed to expand its distribution footprint, enhance operating scale, and drive profitability.